Cargando…

Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome

Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Gurleen, Ashraf, Ibtisam, Peck, Mercedes Maria, Maram, Ruchira, Mohamed, Alaa, Ochoa Crespo, Diego, Malik, Bilal Haider
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688184/
https://www.ncbi.nlm.nih.gov/pubmed/33251070
http://dx.doi.org/10.7759/cureus.11163
_version_ 1783613661154115584
author Kaur, Gurleen
Ashraf, Ibtisam
Peck, Mercedes Maria
Maram, Ruchira
Mohamed, Alaa
Ochoa Crespo, Diego
Malik, Bilal Haider
author_facet Kaur, Gurleen
Ashraf, Ibtisam
Peck, Mercedes Maria
Maram, Ruchira
Mohamed, Alaa
Ochoa Crespo, Diego
Malik, Bilal Haider
author_sort Kaur, Gurleen
collection PubMed
description Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the subcortical white matter of parieto-occipital lobes. In this review, we will discuss the various etiologies and risk factors including some of the most common chemotherapeutic agents and immunosuppressant agents associated with this disorder. We will discuss the mechanism of actions and side effect profiles of a few drugs and their role in causation of PRES. This review article discusses if there is any difference in presentation and imaging findings of PRES caused by cytotoxic agents versus caused by other etiologies. It also highlights the difficulty in management of PRES caused by cytotoxic agents as the discontinuation of these drugs could be life-threatening due to graft rejections or graft versus host disease.
format Online
Article
Text
id pubmed-7688184
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-76881842020-11-27 Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome Kaur, Gurleen Ashraf, Ibtisam Peck, Mercedes Maria Maram, Ruchira Mohamed, Alaa Ochoa Crespo, Diego Malik, Bilal Haider Cureus Neurology Posterior reversible encephalopathy syndrome (PRES) is an entity which is characterized by acute to subacute onset of neurological symptoms like altered mental status, seizures, headaches and other focal neurological deficits. It is diagnosed with the help of MRI findings which typically involve the subcortical white matter of parieto-occipital lobes. In this review, we will discuss the various etiologies and risk factors including some of the most common chemotherapeutic agents and immunosuppressant agents associated with this disorder. We will discuss the mechanism of actions and side effect profiles of a few drugs and their role in causation of PRES. This review article discusses if there is any difference in presentation and imaging findings of PRES caused by cytotoxic agents versus caused by other etiologies. It also highlights the difficulty in management of PRES caused by cytotoxic agents as the discontinuation of these drugs could be life-threatening due to graft rejections or graft versus host disease. Cureus 2020-10-25 /pmc/articles/PMC7688184/ /pubmed/33251070 http://dx.doi.org/10.7759/cureus.11163 Text en Copyright © 2020, Kaur et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Kaur, Gurleen
Ashraf, Ibtisam
Peck, Mercedes Maria
Maram, Ruchira
Mohamed, Alaa
Ochoa Crespo, Diego
Malik, Bilal Haider
Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title_full Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title_fullStr Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title_full_unstemmed Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title_short Chemotherapy and Immunosuppressant Therapy-Induced Posterior Reversible Encephalopathy Syndrome
title_sort chemotherapy and immunosuppressant therapy-induced posterior reversible encephalopathy syndrome
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688184/
https://www.ncbi.nlm.nih.gov/pubmed/33251070
http://dx.doi.org/10.7759/cureus.11163
work_keys_str_mv AT kaurgurleen chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT ashrafibtisam chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT peckmercedesmaria chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT maramruchira chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT mohamedalaa chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT ochoacrespodiego chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome
AT malikbilalhaider chemotherapyandimmunosuppressanttherapyinducedposteriorreversibleencephalopathysyndrome